Gumokimab - CAS 2428381-52-4

Gumokimab (AK 111) is a humanized monoclonal antibody designed to specifically target interleukin-17A (IL-17A) . it functions by competitively inhibiting the binding of IL-17A to its cognate receptor, thereby blocking downstream pro-inflammatory signaling, Gumokimab is a candidate for therapeutic research in psoriasis and ankylosing spondylitis.

IL Receptor, Interleukin

Immunology/Inflammation

2428325

0.989

-20°C

Ice Packs

Inhibitory Antibodies